Since our commonly used RAD6 antibody recognizes an epitope in the carboxyl terminus, this has limited detection of truncated RAD6B forms as well as RAD6B with a modified carboxyl end, such as the intron 5 insertion variant that is present in >50% of the clinical melanomas analyzed. This evidence concerns the gene UBE2B and melanoma.